Interactions
21 results
Applied filters
Commonly used medicines associated with QT interval prolongation
24 August 2026Examples of medicines known to prolong the QT interval. Medicines are grouped by therapeutic class and are not an exhaustive list.
Managing medicines associated with QT interval prolongation
24 August 2026Guidance on patient assessment and management of medicines associated with QT interval prolongation.
Managing complementary products and conventional medicines
16 July 2026Considerations when managing interactions with supplements and complementary, herbal and alternative products, including homeopathy, Chinese and Ayurvedic.
Drug interactions: resources to support clinical decisions
10 June 2026Suggested resources to help healthcare professionals find information on drug interactions
Complementary products: resources to support answering questions
21 May 2026Resources for reviewing interactions with supplements and complementary, herbal and alternative products, including homeopathy, Chinese and Ayurvedic.
Advising on complementary products and conventional medicines
1 December 2025Decision making when advising on interactions with supplements and complementary, herbal and alternative products, including homeopathy, Chinese and Ayurvedic.
Considerations and interactions with GLP-1 receptor agonists
12 November 2025Signposting key risks and interactions of GLP-1 receptor agonists in diabetes, obesity, and weight management.
Managing interactions between medicines and enteral feeds
18 September 2025Learn about the types of feed, some of the most common medicine and feed interactions and how to manage them.
Managing interactions with methotrexate
30 June 2025Guidance on frequently asked questions on medicine interactions with low dose methotrexate.
Managing interactions with direct oral anticoagulants (DOACs)
20 June 2025Interactions with apixaban, dabigatran, edoxaban or rivaroxaban can result in increased risks of a bleed or thrombosis. We advise on management options.